Study Title
A Phase III, Open-Label, Multi-center Clinical Study to Assess the Diagnostic Performance and Safety of 18F-Florastamin PET/CT Imaging in Patients With at Least Intermediate Risk Prostate Cancer
Study Details
Description:
In this study, 18F-Florastamin PET/CT will be performed in patients with at least intermediate risk prostate cancer, to assess the diagnostic performance and safety of 18F-Florastamin PET/CT imaging. This study will first carry out the pilot study (including pharmacokinetics and radiation dosimetry).
Sponsor:
HTA Co., Ltd.Contacts:
Wei Fanfanwei@sysucc.org.cn
+86 13602883007
Government Study Link:
NCT06011304 - Click here to see study onClinicalTrials.gov